Newsroom › International collaboration with UK-based Medical Imaging Partnership

CATEGORY: LATEST NEWS

International collaboration with UK-based Medical Imaging Partnership

Sydney-based Eyes of AI (EAI), which has built one of the world’s most advanced AI-driven radiological software programs, has today announced a collaboration with UK-based diagnostic scanning company Medical Imaging Partnership (MIP) and Prime Health Diagnostics.

EAI Winners

The collaboration will see EAI and MIP partner for a three-stage project with the aim to introduce automated pathology detection software and automated radiology report generation within the ever- expanding world of maxillofacial imaging.

EAI continues to work with Australia’s national science agency, the CSIRO, on automated detection methods for dental and jaw diseases, lesions, and pathologies in Cone Beam CT scans – one of dentistry’s most used imaging modalities. EAI and the CSIRO have been working together since mid- 2022 to develop machine-learning models that can identify normal anatomy and pathological lesions in dental radiographs.

Khoa Le, CEO of EAI said the partnership with MIP will aim to provide dental practices that use MIP’s services with a significant improvement in diagnostic speed and accuracy and ultimately an improved experience for patients.

Our integrated solution providing automated image analysis and reporting will support dentists and dental practitioners to create treatment plans for their patients.

“This automated analysis will help reduce the likelihood of misdiagnoses and missed pathologies – greatly enhancing dentist-patient relationships and patient health outcomes.”

The partnership with MIP comes at a time when there is significantly increased demand by both clinicians and patients for high-quality imaging reports with a short turnaround time, against the backdrop of a finite number of appropriately trained reporters.

An international study (Dental, 2019) that surveyed 7000 adults across the United States, Canada, China, France, Germany India and the UK, found that 95% of dental patients agree that they receive better care with enhanced digital imaging solutions. Two in three patients would consider switching to a digitally equipped and enabled dental practice.

The same survey found that most patients have come to expect more advanced technology and that clinicians' use of technology influences their patients' perceptions of them so much so that it can impact patient attraction and retention.

The partnership with MIP will support EAI’s mission to advance AI technology in the health industry to have a significant positive impact on the lives of people around the world.

Steve Bird, CEO of MIP and Prime Health is excited about the new technological advancements in AI and MIP’s partnership with EAI.

With the ever-increasing advancements in AI technology within our business, we are poised to significantly enhance health services through streamlining and automating processes that are currently manual.

This not only reduces the workload of healthcare professionals but has the potential to improve patient care.

"Our focus on automated imaging report generation is a stride towards increasing capacity for in- depth patient interactions. This ongoing research underscores our commitment to empowering clinicians with cutting-edge tools."

About Eyes of AI

Eyes of AI leverages artificial intelligence to develop advanced segmentation and pathology detection software used by dentists and practitioners worldwide. The Sydney-based business is currently developing the world’s first AI-driven radiology product for all five of the most taken radiographs in the dental industry.

About Medical Imaging Partnership

Medical Imaging Partnership, along with Prime Health Diagnostics, has been delivering high-quality radiology diagnostic services to the NHS and the independent sector in the UK for over a decade. With a footprint that spans several sites across the South- East, London, Surrey and Manchester, MIP and Prime Health services include MRI, CT, Ultrasound, X-Ray, DEXA scans and ultrasound-guided steroid injections.